Professor Steven Charlton

Steven is Vice President, Pharmacology at OMass Therapeutics, and Professor of Molecular Pharmacology and Drug Discovery in the School of Life Sciences at Nottingham University. Prior to joining OMass, he was co-founder and CSO at Excellerate Bioscience, a CRO providing specialist molecular pharmacology support to the pharmaceutical industry. Steven has over 20 years drug discovery experience, most notably at Novartis where he was Director of the Molecular Pharmacology Unit in Respiratory Diseases. In 2007 Steven was named a Novartis Leading Scientist in recognition of his contribution to the field of quantitative pharmacology and to the Novartis pipeline. He is interested in all aspects of the quantitative assessment of drug-target interactions, with a particular interest in the kinetics of ligand binding and signalling.